About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

26 Stan. Tech. L. Rev. 1 (2022-2023)

handle is hein.journals/stantlr26 and id is 1 raw text is: Advertising Medicine: Selling the Cure Robin Feldman* 26 STAN. TECH. L. REV. 1 (2023) ABSTRACT Although most countries forbid advertising medicine to patients, direct-to- consumer advertising has flourished in the United States over the past century. Research shows that the practice prompts inappropriate prescriptions and disadvantages generic competitors, leading to adverse drug reactions and increased prescription drug spending. Nevertheless, a comprehensive regulatory system for direct-to-consumer advertising continues to escape the grasp of policymakers. Regulatory authority has bounced between the Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), where primary jurisdiction now resides. Since the FDA assumed responsibility, the agency's only major regulatory initiative has been to minimize disclosure requirements for advertisements. Enforcement of violations has been similarly lackluster. This Article examines the history of medical advertising and the consequences of insufficient regulation, highlighting the need for a new regulatory model. Rather than leaving responsibility with the FDA or simply transferring it back to the FTC, this Article proposes a coordinated regulatory effort. A coordinated approach to oversight of prescription drug advertising should enable more effective regulation, drawing on the expertise of each agency. In this partnership, the FTC would reprise its past role as monitor and enforcer of prescription drug advertising rules, while the FDA would leverage its scientific expertise to assist in evaluating compliance. By combining the resources and capacities of both agencies, this model offers the potential to fill the problematic gaps in the current regulation of direct-to-consumer advertising. * Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson '54 Distinguished Professor of Law Chair, Director of the Center for Innovation (C4i), University of California Hastings College of the Law. I am grateful to Nathan Brown and Mati Zeff for research assistance and deep insights. I am particularly indebted to Gideon Schor for leading the research team, and I am deeply grateful to the Laura and John Arnold Foundation, whose generous grant helped support my research in this area.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most